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Abstract: The presence of uninhibited side effects of cancer drugs often used in cancer treatment has stimulated the search for
alternative therapeutic approaches. Therefore, anticarcinogenic effects of synthetic, herbal, and fungal drugs have been investigated for
the treatment of various cancer types in recent studies. Lichens, symbiotic organisms of fungi and algae, synthesize metabolites with
significant biological activities. The aim of the current study was to screen the anticancer potential of usnic acid on various types of
nonmalignant cell lines (Vero, L929) and cancer cell lines (CaCo2, RD, Hep2C, HepG2, Wehi). The growth inhibitory effect of usnic acid
was determined by MTT assay. Since this study was also designed to explore mRNA expression profiles, this paper is the first to look into
the effects of usnic acid on apoptotic gene expression. The effects of usnic acid on the gene expression patterns of the tumor suppressor
gene p53, proapoptotic gene Bcl-2, and Bax were studied with qRT-PCR. There was an approximately ninefold decrease in the p53 and
Bcl-2 expression for usnic acid in the Wehi cancer cell line. Consequently, it is concluded that usnic acid has tumor inhibitory properties,
and if indicated by further works like animal studies and clinical trials, it may be used therapeutically in the future.
Key words: Apoptosis, cytotoxicity, qRT-PCR, usnic acid

1. Introduction
Cancer, which is a major disease caused by uncontrolled
cell growth (Hanahan and Weinberg, 2011), can be
treated by methods like surgery, radiation therapy, and
chemotherapy. However, these therapeutic methods have
some unwanted side effects, including the exposure of
nonmalignant cells to cytotoxic agents (Kim et al., 2015).
Natural products are potentially remarkable sources as
new drugs in cancer treatment (Stanojkovic, 2015). Some
researchers have recently screened the effects of natural
metabolites obtained from different biological organisms
on cancer cells. Among them, some have been used in
the pharmaceutical industry. Studies conducted on many
natural metabolites have resulted in the production of
pharmaceutically significant drugs, and many potential
sources of drug therapies still need to be investigated
(Saleem et al., 2010). Approximately 60% of these drugs
are directly or indirectly made up of natural products
(Newman, 2008), one of which is lichens. Lichens,
symbiotic organisms of fungi and algae, synthesize lowmolecular-weight secondary compounds with significant
biological activities and have shown intense antibiotic,
antiproliferative, antioxidant, anti-HIV, anticancer,
immunomodulator, and antiprotozoal activities.
* Correspondence: dcansaran@yahoo.com
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Lichens are known to synthesize more than 1000 various
secondary metabolites produced by the fungal partner.
Although lichen metabolites demonstrate biological roles,
one of their main disadvantages is their slow growth rate
in laboratory conditions. Therefore, lichens have received
little attention in the biomedical field. However, presently,
lichens are more successfully cultured in laboratory
settings thanks to advances in technology (Yamamoto et
al., 1985, 1987, 1993; Stocker-Wörgötter, 2001; StockerWörgötter and Elix, 2002; Behera et al., 2006). Thus, lichen
species and their related metabolites can now be used in
the large volumes necessary for commercial exploitation
in the pharmaceutical field.
As a result of some studies, lichens and their secondary
metabolites have demonstrated cell proliferation by
regulating the cell cycle and an increment in cell death by
inducing apoptosis or necrosis (Nguyen et al., 2014; Ari
et al., 2014; Coskun et al., 2015; Kim et al., 2015; Kılıç
et al., 2016). The mechanism of many anticancer drugs
in the pharmaceutical industry is based on their ability
to induce apoptosis (Motomura et al., 2008; Florea and
Busselberg, 2011). Apoptosis that occurs through different
ways can be enhanced in cells. First, candidate molecules
suppress the proliferation of malignant cells, and apoptosis
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increases thereafter and shows a mechanistic approach to
cancer chemoprevention and chemotherapy (Alhazmi
et al., 2014). In an article by Singh et al. published in
2013, the cell death ratio of human lung carcinoma was
determined after 25–100 µM usnic acid application
for 24 and 48 h. They observed that usnic acid induced
mitochondrial membrane depolarization and showed
approximately twofold change in apoptotic cells as regards
flow cytometry analyses (Singh et al., 2013). Zuo et al.
explored the antitumoral activity of usnic acid in human
breast cancer MCF-7 by in vitro and in vivo experiments.
They demonstrated that usnic acid induces apoptosis
of MCF-7 cells by reactive oxygen species generation,
c-Jun amino-terminal kinases activation, mitochondrial
dysfunction, cytochrome-c release, and caspase activation
(Zuo et al., 2015). Nguyen et al. showed the cytotoxic
activity of 17 lichen species on some human cancer cells
and determined molecular mechanisms of their anticancer
activity. The results of their study revealed that secondary
metabolites extracted from Flavocetraria cucullata show
significant anticancer effects on cancer cell lines through
the induction of apoptosis and suppression of tumorigenic
potentials (Nguyen et al., 2014).
Usnic acid, a lichen secondary metabolite, has been
extensively studied since its first isolation in 1844. Its
chemical formula is 2,6-diacetyl-7,9-dihydroxy-8,9bdimethyl-1,3 (2H, 9bh). The mechanism of usnic acid
needs to be investigated in greater detail to reach clinical
trials. Usnic acid has been mainly investigated for cell
proliferation; however, no research has been conducted to
look into the effect of usnic acid on cancer cell lines for
the molecular mechanism of apoptosis at the mRNA level.
Therefore, this study was designed to determine the effect
of usnic acid-induced apoptosis in the examined cancer
cell lines by apoptosis-related gene expression. In order to
test this, we determined the role of usnic acid in inhibiting
cell growth and modulating the expression of the p53, Bax,
and Bcl-2 genes.
2. Materials and methods
2.1. Lichen samples
Samples of Usnea diffracta were collected from the
mountainous forest region in Trabzon-Uzungöl-Soğanlı,
Turkey (44°84′N, 37°61′E, 1799 m) by the second author.
Identification of the collected samples was done according
to the keys of Wirth (1995) and Purvis et al. (1992). Fresh
samples were stored at 4 °C until analysis. Commercial
usnic acid was purchased from Sigma and 400 µM usnic
acid, which is the stock concentration, was prepared in 14
mM dimethyl sulfoxide (DMSO). Appropriate dilutions of
this stock solution (200, 100, 50, 25, 12.5, and 6.25 µM)
were made with DMSO.

2.1.1. Isolation and identification of usnic acid
Air-dried Usnea diffracta lichens were extracted with 512 g
of light petroleum at low temperature (2–4 °C). Afterwards,
the sample was recrystallized ten times with pure ethanol
and 93.6 mg of usnic acid was obtained. The usnic acid
extract was incubated in darkness until high-performance
liquid chromatography (HPLC) analysis was conducted.
Before the experiments commenced, the extract was
filtered through a 0.45-µm filter, and 20 µL of extract was
analyzed by being injected into the HPLC system.
Usnic acid (1 mg/mL) was prepared in acetone and
used as a stock solution. An appropriate further dilution
was made with acetone. All standards were placed in
an autosampler and analyzed. Calibration curves were
prepared with seven various usnic acid concentrations
for linear regression analysis. A Thermo Finnigan HPLC
system equipped with a Surveyor LC pump, Surveyor
photodiode array detector, Surveyor autosampler, and data
processor (ChromQuest 4.01) was used. HPLC analysis
of usnic acid was performed according to the protocol of
Cansaran et al. (2007). Each analysis was carried out in
triplicate.
2.2. Cell culture
Human colorectal adenocarcinoma cell line CaCo2, human
hepatocellular carcinoma cell line HepG2, human (HeLa
derivative) cervix carcinoma cell line Hep2C, human
rhabdomyosarcoma cell line RD, mouse fibrosarcoma
cell line Wehi, mouse subcutaneous connective tissue
cell line L929, and African green monkey kidney cell line
Vero were obtained from Animal Cell Culture Collection
of the Foot and Mouth Disease Institute, Turkey. CaCo2,
HepG2, Hep2C, RD, L929, and Vero cells were cultured
in Dulbecco’s modified Eagle medium (PAA Laboratories,
Austria); Wehi was cultured in RPMI-1640 containing
10% fetal bovine serum (Gemini Byproducts, USA), 2 mM
L-glutamine, and 1% penicillin and streptomycin. Cells
were maintained in a humidified incubator at 37 °C with
5% CO2.
2.3. Cell viability assay
CaCo2, HepG2, Hep2C, RD, Wehi, L929, and Vero cells
were plated into a 96-well culture plate at a density of 1 ×
104 cells per well. Commercial usnic acid and natural usnic
acid were then diluted to appropriate concentrations and
immediately applied to the cells. Concentration- and timedependent cytotoxicity were assessed by having the cells
exposed to usnic acid at concentrations of 6.25, 12.5, 25,
50, 100, 200, and 400 µM for 24, 48, and 72 h. Viability of
the cells was evaluated using the (3-4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction
method. First, 50 µL of MTT was added to the medium for
4 h of incubation. The insoluble formazan crystals within
the cells were extracted by 100 µL of isopropanol, and the
absorbance was measured using a microplate reader at a
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wavelength of 570 nm. All experiments were performed
in six independent biological and technical replicates.
EC50 values and survival rates were calculated by obtained
absorbance values. Absorbance values were converted to a
logarithm base for the calculation of EC50 values, and the
calculations were then performed using GraphPad Prism 6.
2.4. Total RNA extraction and cDNA synthesis
Examined cells (5 × 104 cells/well) were cultured in
6-well plates. Cells were treated with EC50 concentrations
of usnic acid for 48 h. After the incubation period, the
culture medium was aspirated, and total RNA was isolated
from the cultured cells using a TRIzol reagent (GENEzol,
Geneaid Biotech, Taiwan) according to the manufacturer’s
protocol. Briefly, the examined cells were harvested for
RNA extraction by centrifugation, the supernatants were
discarded, and 500 µL of TRIzol was added to the cells
and homogenized for 1 min. Chloroform (100 µL) was
then added and vortexed for 15 s. Samples were incubated
for 3 min at room temperature and centrifuged for 15
min at 14,000 rpm (4 °C), and the supernatants were
transferred to new tubes. An equal volume of isopropanol
was added, incubated for 10 min at room temperature,
and then centrifuged for 10 min at 14,000 rpm (4 °C).
The supernatants were discarded, and 800 µL of 75%
ethanol was added to the pellet, followed by centrifugation
for 5 min at 13,200 rpm (4 °C). The supernatants were
discarded, and the pellets were suspended in 20 µL of
DEPC-water and treated with RNase-free DNase I (Takara,
China). Purity and concentration of the total RNA were
determined by spectrophotometry using the 260 nm/280
nm ratio (NanoDrop 1000, Thermo Scientific, USA)
and 1% agarose gel electrophoresis. First-strand cDNA
was synthesized based on the total RNA of each sample
using the Roche First Strand cDNA Synthesis Kit (Roche,
Switzerland) according to the manufacturer’s protocol.
cDNA synthesis was applied with 2 µg of RNA, 2.5 µM
anchored-oligo (dT)18, 1X Transcriptor High Fidelity
Reverse Transcriptase reaction buffer, 20 U of protector

RNase inhibitor, 1 mM deoxynucleotide mix, and 10 U
Transcriptor High Fidelity Reverse Transcriptase at the
final concentration. Afterwards, it was continued at 10
min at 65 °C, 30 min at 55 °C, and 5 min at 85 °C.
2.5. Real-time PCR analysis
Real-time quantitative PCR (qRT-PCR) was conducted
with the Roche Light Cycler 480 Real Time, using SYBR
Green I Master. Sequences of tumor suppressor gene p53,
antiapoptotic gene Bcl-2, and the Bax gene were designed
with the Primer3 program (Table). Glyceraldehyde3-phosphate dehydrogenase (GAPDH) was used as a
housekeeping gene. All experiments were performed in
three independent biological and technical triplicates.
Melting curve analysis was performed to determine
the effectiveness of PCR and to observe if there was any
dimer formation. p53, Bcl-2, Bax, and the reference gene
(GAPDH) were optimized by the testing of real-time PCR
reactions. Reaction conditions after predenaturation were
studied at 10 min at 95 °C and 40 cycles of 10 s at 95 °C, 30
s at 60 °C, and 8 s at 72 °C.
2.6. Statistical analysis
The relative mRNA expression profile of the three targeted
genes was normalized with the reference gene (GAPDH)
and calculated by 2−ΔΔCt method. Statistical analyses were
conducted with GraphPad Prism software (Version 5.0,
San Diego, CA, USA) and one-way ANOVA with SPSS
15.0 (SPSS Inc., Chicago, IL, USA). Fisher’s least significant
difference test at a P-value of 0.05 significance was applied.
3. Results
3.1. Identification of usnic acid
Quantitative analysis of usnic acid in Usnea diffracta
species was performed with HPLC. Identification of peaks
in chromatograms of lichen extracts was attained with
the comparison of retention times with that of standard
usnic acid. A sample representing these chromatograms is
shown in Figure 1. HPLC retention time was 12.22 min at
1.6 mL min–1 flow rate.

Table. Primer sequences of the examined genes.
Primers
P53
Bcl-2
Bax
GAPDH
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Sequence (5’→3’)
5’ AACGGTACTCCGCCACC 3’
5’ CGTGTCACCGTCGTGGA 3’
5’ CTGCACCTGACGCCCTTCACC 3’
5’ CACATGACCCCACCGAACTCAAAGA 3’
5’ TCCCCCCGAGAGGTCTTTT 3’
5’ CGGCCCCAGTTGAAGTTG 3’
5’ AACGGGAAGCTTGTCATCAATGGAAA 3’
5’ GCATCAGCAGAGGGGGCAGAG 3’

Product
length (Pl)

Annealing
temperature (Tm)

94

60.0 °C

119

65.0 °C

68

65.0 °C

194

60.0 °C
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Figure 1. A sample chromatogram for the analysis of usnic acid from Usnea diffracta by
HPLC [solvent (tR = 5.4 min); usnic acid (tR = 12.22 min)].

3.2. Cell death
The testing of natural and commercial usnic acid
secondary metabolites on various cell lines proved a
concentration- and time-dependent action as evaluated
by the MTT cytotoxicity assay. According to the results,
natural and commercial usnic acids had similar activity
ratios against all nonmalignant and cancer cell lines. There
was no significant result of either usnic acid secondary
metabolite. Cell viability of Hep2C cancer cells exposed
to natural and commercial usnic acids for 48 h is given
in Figure 2. Reduction in RD cancer cell viability with
usnic acid treatment at a concentration of 6.25 µM to 25
µM after 24 h ranged from 2.1% to 27.2%, whereas after
48 and 72 h, it respectively ranged from 31.3% to 69.1%

and 57.7% to 85.9%, as shown in Figure 3. It should be
noted that the 6.25 and 25 µM concentrations of usnic
acid treatments after 48 h were found to show significant
cytotoxic effects on the examined cancer cell lines (P <
0.05) (Figure 3). Additionally, it was found in our study
that usnic acid, which had a cell viability-reducing effect
on all cancer cells, was most effective on the RD and
Wehi cancer cell lines (P < 0.05). This result suggests that
usnic acid inhibited the proliferation of the examined
cancer lines. It is surprising that there was no significant
decrease in cell viability of the L929 and Vero cell lines
at the increasing concentrations/times of usnic acid
application, as shown in Figure 4 (P < 0.05). One of the
most important results of the current study is that usnic

Figure 2. Dose-response curves for the effect of natural and commercial usnic acid on Hep2C cell line
for 48 h (values are statistically significant at *P < 0.05 compared to the respective control).
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Figure 3. Comparative representation of the RD cell line (values are statistically significant
at *P < 0.05 compared to the respective control).

Figure 4. Comparative representation of the Vero cell line (values are statistically
significant at *P < 0.05 compared to the respective control).

acid inhibited cancer lines but had very little inhibiting
effect on nonmalignant cell lines. Particularly, cancer can
be treated by chemotherapy, and this type of therapy uses
chemical compounds that inhibit cytotoxicity in cancer
cells. As a consequence, the application of chemotherapy
may cause numerous unwanted side effects. In order to
overcome these negative side effects, usnic acid is found
to be a promising source for cancer treatment.
Vast differences among the examined cell lines as
well as different sensitivities to usnic acid secondary
metabolites were shown by calculating the half maximal
effective concentrations (EC50). EC50 values for usnic acid
on the CaCo2, HepG2, Hep2C, RD, and Wehi cancer cell
lines were 7.05, 15.4, 21.8, 22.9, and 15.8 µM, respectively.
3.3. Gene expression analysis
Commercial usnic acid was selected in our gene
expression studies since cytotoxic effects of commercial
and natural usnic acids were similar. After having exposed
the tested cell lines to usnic acid doses corresponding to
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EC50 values for 48 h, total RNAs were successfully isolated
from all cell lines except the CaCo2 and HepG2 cell lines.
Therefore, qRT-PCR results of the CaCo2 and HepG2 cell
lines were not included in this study. RNA concentrations
were in the range of 157 to 261 ng/µL, and 230/260 nm
ratios were between 0.87 and 0.99. The integrity of the
extracted RNAs was also evaluated by electrophoresis.
So as to investigate the effects of usnic acid on molecular
mechanisms related to apoptosis in cancer cell lines, the
expression of some apoptosis related genes (Bax, Bcl2, and p53) was analyzed by qRT-PCR. There are no
available data on the effect of usnic acid on proapoptotic
and antiapoptotic gene expression in different cancer
and nonmalignant cell lines. Therefore, qRT-PCR assay
of some apoptosis-related genes in the cell lines after
exposure to usnic acid is one of the valuable points of
the current study. Transcription changes of the examined
genes subjected to EC50 doses of usnic acid treatments are
given in Figures 5a–5d.
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Figure 5. Usnic acid effect on mRNA levels of RD, Hep2C, HepG2, Wehi, and Vero
cell lines. Expression level of usnic acid on mRNA was determined using qRT-PCR
repeated three times after optimization. Values are statistically significant at *P < 0.05
compared to the respective control.

After the application of usnic acid, an approximately
threefold decrease was seen in Bax; however, the Bcl-2
antiapoptotic gene and p53 tumor suppressor gene were
decreased fivefold in the Hep2C cell line when compared

to the control group (P < 0.05) (Figure 5a). There was
an 8-fold and 2.5-fold decrease in the expression of the
Bcl-2 and p53 genes in the RD cell line when compared
to the control group, respectively (P < 0.05) (Figure 5b).
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Usnic acid increased the transcripts of the Bax gene by
twofold. Exposed to usnic acid, all examined suppressor
gene levels were significantly underexpressed in the Wehi
cell line. While there was an approximately 9.5- and 8.5fold reduction in the gene expression of Bcl-2 and p53,
respectively, there was a 3.5-fold increase in Bax gene
expression when compared to the control group (P < 0.05)
(Figure 5c). It is obvious that all concentrations of usnic
acid led to an increase in the Bax gene and decrease in Bcl2 and p53 genes in mRNA levels when compared to the
unexposed control sample. Contrary to cancer cells, there
was not a significant decrease in gene expression in the
Vero nonmalignant cell line (P < 0.05) (Figure 5d).
4. Discussion
It was shown in this study that there was no significant
difference in the source of the usnic acid (whether natural
or commercial) secondary metabolite against cancer lines.
The results found in this study revealed that 6.25 and 25
µM usnic acid concentrations have important cytotoxic
and apoptotic effects on cancer cell lines, whereas
nonmalignant cell lines, particularly L929, maintain their
life in spite of high doses of usnic acid. Almost a twofold
increase occurred in p53 and Bax expression for usnic
acid, which suggests that usnic acid has tumor-inhibitory
properties. This study confirmed that usnic acid plays a
major role in the regulation of apoptosis of cancer cells.
Therefore, our results add novel insight into the anticancer
activity of lichen seconder metabolites.
Einarsdottir et al. investigated the inhibitory effect of
pure (+)-usnic acid extracted from Cladonia arbuscula
and (-)-usnic acid from isolated Alectoria ochroleuca on
the proliferation of T-47D and Capan-2. It is of interest to
compare the effects of the two enantiomers since different
isomers of usnic acid can have different proliferation
effects. No difference was determined between the two
enantiomers of usnic acid (Einarsdottir et al., 2010). The
present study compared natural usnic acid extracted from
Usnea diffracta collected from Turkey with commercial
usnic acid. Similar results were obtained for the two
usnic acid types (P < 0.05). In this regard, it is noted that
an effective novel drug source of usnic acid collected
from Usnea diffracta lichen species will be possible for
commercial production.
Chen et al. reported the role of autophagy on the
toxicity of usnic acid. HepG2 cells were treated with
different usnic acid concentrations and times (2, 6, 24, and
48 h) in order to determine the cytotoxic effect of usnic
acid. It was found that usnic acid exhibits a time- and
concentration-dependent growth-inhibiting effect, and
lactate dehydrogenase (LDH) release occurred only after
24 h of exposure to 12.5 µM or 48 h of exposure to 3.13 µM
usnic acid. No significant LDH release was observed after
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2 or 6 h of exposure to the tested concentrations of usnic
acid (Chen et al., 2014). In the present study, according to
the MTT assay results, usnic acid exhibited a time- and
concentration-dependent growth-inhibiting effect on the
CaCo2, HepG2, Hep2C, RD, and Wehi cancer cell lines. In
our study, it was observed for the HepG2 cell line that the
most growth-inhibiting effect of usnic acid occurred after
48 h of exposure to 15 µM.
Singh et al. determined the anticancer potential of
usnic acid in A549 cells. Usnic acid treatment (25, 50,
and 100 µM) for 24 and 48 h resulted in a dose- and timedependent decrease in cell growth and proliferation. In
addition, the cell death effect was further increased after
48 h of treatment with usnic acid. As a result of our study,
it was determined that 48 h of usnic acid treatment was
the most active of all time parameters. Consistent with cell
death data, it was found that usnic acid treatment for 48 h
showed a dose-dependent increase in apoptotic cells (Singh
et al., 2013). In the present study, usnic acid exposure was
conducted at different concentrations and for 24, 48, and
72 h on various cancer cell lines. According to the MTT
assay results, commercial and natural usnic acid secondary
metabolites displayed cytotoxic effects on tested cell lines
depending on the duration of exposure. Particularly after
48 and 72 h, 12.5 µM and higher concentrations of usnic
acid significantly reduced cell viability (P < 0.05). The
percentage of viable cells showed higher cytotoxic effects
on cancer cell lines after treatment for 48 h with 25 µM
commercial usnic acid or more.
Brisdelli et al. emphasized the effects of diffractaic
acid, lobaric acid, usnic acid, vicanicin, variolaric acid, and
protolichesterinic acid lichen metabolites on proliferation
and viability of MCF-7, HeLa, and HCT-116. Cell viability
reducing activity of usnic acid on HeLa and HCT-116 cells
was found to be in the concentration range of 25–100 µM.
It has also been found that usnic acid is the most potent
cytotoxic agent on MCF-7, HeLa, and HCT-116 cells
(Brisdelli et al., 2013). In our study, the most cytotoxic
effect of treatment with commercial and natural usnic
acid was observed on RD and Wehi cells. Usnic acid could
potentially represent an alternative source for cancer
therapy.
Backorova et al. extensively studied the antiproliferative/
cytotoxic effects of parietin, atranorin, usnic acid, and
gyrophoric acid lichen secondary metabolites in A2780,
HeLa, MCF-7, SK-BR-3, HT-29, HCT-116 p53 +/+, HCT116 p53, HL-60, and Jurkat cancer cell lines. They found
that usnic acid was the most effective secondary metabolite
with an approximately 50 µM usnic acid concentration
effect on all cell lines (excluding HeLa cells and HCT-116
p53 +/+). Usnic acid and atranorin were demonstrated
to induce apoptosis and inhibit cell proliferation in all
tested cell lines (Backorova et al., 2011). In our study, it
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was found that usnic acid after 48 h of exposure to 6–25
µM concentration showed a potent cytotoxic effect on all
tested cell lines.
Koparal et al. investigated the cytotoxic activities
of (+)-usnic acid and (-)-usnic acid on V79, A549, and
human lymphocyte cells. They found that 100 µg mL–1
(+)-usnic acid and 100 and 50 µg mL–1 (-)-usnic acid
concentrations induced cytotoxic effects in human
lymphocytes. A significant increase in apoptotic cells was
found at 25 and 30 µg mL–1 (-)-usnic acid and 50 µg mL–1
(+)-usnic acid concentrations. According to MTT assay
results, (+)-usnic acid showed relatively more cytotoxic
effects than (-)-usnic acid in A549 cells. Even at low doses
of usnic acid, the two enantiomers were found to be more
effective in the death and control of cancer cells compared
to nonmalignant cell lines (Koparal et al., 2006). In our
study, treatment with usnic acid showed a less cytotoxic
effect on L929 and Vero cells than the cancer cell lines. The
effect of usnic acid was confirmed to beat very low rates in
nonmalignant cell lines by both MTT assay and qRT-PCR
at the mRNA level (P < 0.05).
Apoptosis could occur as a result of many mechanisms.
Agents suppress the proliferation of cancer cells via
enhancing apoptosis. Afterwards, cancer prevention and
treatment is ensured through these agents. To the best of
our knowledge, this is the first study on the apoptosisrelated gene expression properties of usnic acid against
different cancer and nonmalignant cell lines.
Backorova et al.explored the apoptotic effects of
parietin, atranorin, usnic acid, and gyrophoric acid on
A2780 and HT-29 cancer cell lines. It was found that
usnic acid and atranorin are more effective anticancer
metabolites when compared with parietin and gyrophoric
acid. The 50 and 100 µM concentrations of usnic acid
remarkably increased the proportion of annexin V-positive
cells after 24 h of exposure or more. It has been shown that
usnic acid and atranorin are activators of programmed
cell death in A2780 and HT-29 cells as a result of the
detection of PARP, p53, Bcl-2/Bcl-xL, Bax, p38, and pp38
protein expressions (Backorova et al., 2012). Furthermore,
we also demonstrated gene expression of usnic acid in
cancer and nonmalignant cell lines without protein data.
In the past decades, many studies focused on cytotoxic
effects of usnic acid. However, our study is scientifically
validated by mRNA levels for apoptosis mechanisms. This
study determined that usnic acid inhibits cell growth in
several types of cancer cells by regulating genes related
to apoptosis. Similar observations were made by Zu et
al. by qRT-PCR for emodin (Zu et al., 2015). They found
that emodin is significantly increased with Bax levels and
decreased with p53 and Bcl-2 (P < 0.05). The study by Zu
et al. and our study provide similar results of alternative
source-induced apoptosis of cancer cells.

Song et al. found that treatment with usnic acid
significantly suppresses mouse corneal neovascularization
via inhibiting vascular endothelial growth factor (VEGF)activated VEGFR2 phosphorylation (Song et al., 2012).
It was determined that usnic acid functions as a tumor
angiogenesis inhibitor by suppressing VEGFR2-mediated
AKT and extracellular signal-regulated kinase (ERK
1/2) signaling pathways. They also established that
usnic acid does not only remarkably inhibit endothelial
cell proliferation, migration, and tube formation, but
also induces morphological changes and apoptosis in
endothelial cells (Song et al., 2012). Usnic acid showed
apoptotic effects on cancer cell lines tested in our study
with the Bax, Bcl-2, and p53 genes. After treatment with
usnic acid, the most reduction of expressions of Bcl-2 and
p53 genes was in the Wehi cell line with 9.5-fold decrease
in Bcl-2 when compared to the control group (P < 0.05).
Thus, the most apoptotic effect of usnic acid occurred in
this cell line. The most commonly mutated gene was p53,
which regulates the cell cycle and has a significant role
in the recovery of damaged cells by apoptosis. According
to the results of this study, the expression levels of p53
significantly decreased exposure to usnic acid at the EC50
level (P < 0.05). Therefore, our study revealed that usnic
acid induced apoptosis by regulating proapoptotic genes.
Wang et al. analyzed five most-used reference genes
and ten anticancer drug-related genes in tissue samples
from lung, rectal, colon, gastric, esophageal, and breast
tumors using qRT-PCR. They found that most tested target
genes, except for HER2, display high expression levels in
lung, rectal, and colon tumors and low expression levels in
breast, gastric, and esophageal tumors. It was determined
that HER2 shows the highest expression level in breast
tumors and the lowest expression in esophageal tumors.
Moreover, lung cancer had the highest epidermal growth
factor receptor (EGFR) expression level among the tumors
while breast cancer had the lowest EGFR expression level
(Wang et al., 2015). In the present study, Bax, Bcl-2, and
p53 gene expression levels in cancer cell lines (Hep2C,
RD, and Wehi) and a nonmalignant cell line (Vero) were
researched. According to the results, Bax, Bcl-2, and p53
gene expression in the Vero cell line reached the highest
levels for nonmalignant cell lines when compared with
controls (P < 0.05). The changes in p53 gene expression in
the Wehi cell line was found to have the highest levels in
all examined cancer cell lines. All tested gene expression
levels were found to be low in the Hep2C cell line when
compared with other examined cancer cell lines (RD and
Wehi) (P < 0.05).
In conclusion, our study showed that usnic acid inhibited
different cancer growths in vitro. In order to understand
the molecular mechanisms of the apoptosis pathway, usnic
acid secondary metabolites were studied by qRT-PCR. To
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date, no study has investigated the gene expression profiles
of cancer cells treated with usnic acid. As a result of our
study, the antiapoptotic gene Bcl-2 was downregulated
and the proapoptotic gene Bax was upregulated after the
examined cancer cells were treated with usnic acid. Studies
have suggested that usnic acid might play a significant
role in the apoptosis pathway. This study revealed that
usnic acid seems to be suitable as an anticancer therapy
to solve this public health problem. With further studies

on additional molecular mechanisms and further clinical
testing to pinpoint the anticancer activity of lichen species,
their secondary metabolites can be revealed, and thus usnic
acid could be used in cancer chemotherapy.
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